ROCK1 and experimental autoimmune encephalomyelitis: ROCK1/ROCK2 inhibitors rescued the efficacy of BBB damage in several CNS diseases, including experimental autoimmune encephalomyelitis, cerebral ischemia, and intracerebral hemorrhage [39].